AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 89 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,131,101 | -40.9% | 983,602 | -5.4% | 3.24% | -49.1% |
| Q2 2023 | $17,130,532 | +40.9% | 1,039,474 | -21.7% | 6.37% | +72.0% |
| Q1 2023 | $12,156,209 | +148.0% | 1,327,097 | +93.9% | 3.70% | +86.8% |
| Q4 2022 | $4,901,000 | +237.1% | 684,556 | +361.4% | 1.98% | +242.9% |
| Q3 2021 | $1,454,000 | -31.2% | 148,355 | -52.7% | 0.58% | -16.4% |
| Q2 2021 | $2,112,000 | +45.8% | 313,795 | +95.8% | 0.69% | +92.5% |
| Q1 2021 | $1,449,000 | – | 160,256 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |